RESEARCH-USE BIOSIMILAR ANTIBODY
Erlizumab
Monoclonal antibody · IgG1
Erlizumab (rhuMAb) is a monoclonal antibody against the Integrin b2/ITGB2/CD18 subunit of the Mac-1 receptor. Erlizumab can reduce reperfusion injury in myocardial infarction.
TARGETITGB2
YMonoclonal antibody
CATALOGSC-BS-570
CATALOG NUMBERSC-BS-570
MOLECULAR WEIGHTApprox. 49.293 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Erlizumab (rhuMAb) is a monoclonal antibody against the Integrin b2/ITGB2/CD18 subunit of the Mac-1 receptor. Erlizumab can reduce reperfusion injury in myocardial infarction.
Erlizumab is a recombinant research-use antibody directed against ITGB2.